Development of a physiologically based pharmacokinetic model for bisphenol A in pregnant mice.

Bisphenol A (BPA) is a weakly estrogenic monomer used to produce polymers for food contact and other applications, so there is potential for oral exposure of humans to trace amounts via ingestion. To date, no physiologically based pharmacokinetic (PBPK) model has been located for BPA in pregnant mice with or without fetuses. An estimate by a mathematical model is essential since information on humans is difficult to obtain experimentally. The PBPK model was constructed based on the pharmacokinetic data of our experiment following single oral administration of BPA to pregnant mice. The risk assessment of bisphenol A (BPA) on the development of human offspring is an important issue. There have been limited data on the exposure level of human fetuses to BPA (e.g. BPA concentration in cord blood) and no information is available on the pharmacokinetics of BPA in humans with or without fetuses. In the present study, we developed a physiologically based pharmacokinetic (PBPK) model describing the pharmacokinetics of BPA in a pregnant mouse with the prospect of future extrapolation to humans. The PBPK model was constructed based on the pharmacokinetic data of an experiment we executed on pregnant mice following single oral administration of BPA. The model could describe the rapid transfer of BPA through the placenta to the fetus and the slow disappearance from fetuses. The simulated time courses after three-time repeated oral administrations of BPA by the constructed model fitted well with the experimental data, and the simulation for the 10 times lower dose was also consistent with the experiment. This suggested that the PBPK model for BPA in pregnant mice was successfully verified and is highly promising for extrapolation to humans who are expected to be exposed more chronically to lower doses.

[1]  B. Shin,et al.  MATERNAL-FETAL DISPOSITION OF BISPHENOL A IN PREGNANT SPRAGUE-DAWLEY RATS , 2002, Journal of toxicology and environmental health. Part A.

[2]  P. Ryan,et al.  Effect of neonatal rat bisphenol a exposure on performance in the Morris water maze. , 2003, Journal of toxicology and environmental health. Part A.

[3]  Tim Morris,et al.  Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.

[4]  P. Cooke,et al.  A Physiologically Based Approach To the Study of Bisphenol a and Other Estrogenic Chemicals On the Size of Reproductive Organs, Daily Sperm Production, and Behavior , 1998, Toxicology and industrial health.

[5]  H. Yokota,et al.  Bisphenol a glucuronide, a major metabolite in rat bile after liver perfusion. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[6]  Beom Soo Shin,et al.  PHYSIOLOGICALLY BASED PHARMACOKINETICS OF BISPHENOL A , 2004, Journal of toxicology and environmental health. Part A.

[7]  C. Portier,et al.  Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. , 1997, Toxicology and applied pharmacology.

[8]  Jeffery M. Gearhart,et al.  A Partition Coefficient Determination Method for Nonvolatile Chemicals in Biological Tissues , 1994 .

[9]  E J O'Flaherty,et al.  A physiologically based kinetic model of rat and mouse gestation: disposition of a weak acid. , 1992, Toxicology and applied pharmacology.

[10]  A. Bikhazi,et al.  Transport of prostaglandins through normal and diabetic rat hepatocytes. , 1983, Journal of pharmaceutical sciences.

[11]  H. Takano,et al.  Prenatal exposure to bisphenol A up‐regulates immune responses, including T helper 1 and T helper 2 responses, in mice , 2004, Immunology.

[12]  Midori Yoshida,et al.  Maternal exposure to low doses of bisphenol a has no effects on development of female reproductive tract and uterine carcinogenesis in Donryu rats. , 2004, The Journal of reproduction and development.

[13]  M. Delp,et al.  Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.

[14]  T. Zacharewski,et al.  In Vitro and in Vivo Interactions of Bisphenol A and Its Metabolite, Bisphenol A Glucuronide, with Estrogen Receptors α and β , 2001 .

[15]  J. Corton,et al.  Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.

[16]  K. Nakao,et al.  Thyroid hormone action is disrupted by bisphenol A as an antagonist. , 2002, The Journal of clinical endocrinology and metabolism.

[17]  R. Cooper,et al.  Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  J. Ashby,et al.  Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans. , 2001, The Journal of pharmacology and experimental therapeutics.

[19]  Y. Yokouchi,et al.  Depth profiles of volatile halogenated hydrocarbons in seawater in the Bay of Bengal. , 2001, Chemosphere.

[20]  H. Kabuto,et al.  Exposure to bisphenol A during embryonic/fetal life and infancy increases oxidative injury and causes underdevelopment of the brain and testis in mice. , 2004, Life sciences.

[21]  I. Chahoud,et al.  Parent bisphenol A accumulation in the human maternal-fetal-placental unit. , 2002, Environmental health perspectives.

[22]  N. Uehara,et al.  Effects of maternal xenoestrogen exposure on development of the reproductive tract and mammary gland in female CD-1 mouse offspring. , 2004, Reproductive toxicology.

[23]  K. Ukena,et al.  Dendritic growth in response to environmental estrogens in the developing Purkinje cell in rats , 2004, Neuroscience Letters.

[24]  H. Ishitsuka,et al.  Investigation of 5‐FU disposition after oral administration of capecitabine, a triple‐prodrug of 5‐FU, using a physiologically based pharmacokinetic model in a human cancer xenograft model: comparison of the simulated 5‐FU exposures in the tumour tissue between human and xenograft model , 2001, Biopharmaceutics & drug disposition.

[25]  Y. Kuroda,et al.  Behavioral Alterations in Response to Fear-Provoking Stimuli and Tranylcypromine Induced by Perinatal Exposure to Bisphenol A and Nonylphenol in Male Rats , 2004, Environmental health perspectives.

[26]  N. Manabe,et al.  Disposition of bisphenol A in pregnant mice and fetuses after a single and repeated oral administration , 2005 .

[27]  Joshua T. Cohen,et al.  Weight of the Evidence Evaluation of Low-Dose Reproductive and Developmental Effects of Bisphenol A , 2004 .

[28]  L. R. Harris,et al.  Normal reproductive organ development in CF-1 mice following prenatal exposure to bisphenol A. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[29]  K A Thayer,et al.  Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. , 1997, Environmental health perspectives.

[30]  Y. Taketani,et al.  Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. , 2002, Human reproduction.

[31]  K Krishnan,et al.  An algorithm for predicting tissue: blood partition coefficients of organic chemicals from n-octanol: water partition coefficient data. , 1995, Journal of toxicology and environmental health.

[32]  K. Grandien,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .

[33]  T. Iguchi,et al.  Bisphenol A Exerts Thyroid-Hormone-Like Effects on Mouse Oligodendrocyte Precursor Cells , 2004, Neuroendocrinology.